Skip to content

The Impact of Preoperative Administration of Esketamine Combined with Dexmedetomidine Hydrochloride Nasal Spray on Early Postoperative Recovery Quality in Endoscopic Sinus Surgery

The Impact of Preoperative Administration of Esketamine Combined with Dexmedetomidine Hydrochloride Nasal Spray on Early Postoperative Recovery Quality in Endoscopic Sinus Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111948
Enrollment
Unknown
Registered
2025-11-07
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This study aims to investigate the effect of preoperative administration of esketamine combined with hydrochloride dexmedetomidine nasal spray on the quality of early recovery after endoscopic sinus surgery.

Interventions

C:The dexmedetomidine nasal spray group (Group D), the esketamine group (Group E), and the esketamine combined with dexmedetomidine nasal spray group (G
the esketamine group (Group E):The dexmedetomidine nasal spray group (Group D) and the esketamine combined with dexmedetomidine nasal spray group (Group DE)
the dexmedetomidine nasal spray group (Group D):The eszopiclone group (Group E) ? the eszopiclone combined with dexmedetomidine nasal spray group (Group DE)
the eszopiclone combined with dexmedetomidine nasal spray group (Group DE):the dexmedetomidine nasal spray group (Group D) and the esketamine group (Group E)

Sponsors

Shandong Second Provincial General Hospital, Shandong Provincial ENT Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years old; 2. American Society of Anesthesiologists (ASA) classification I-III; 3. Scheduled to undergo endoscopic sinus surgery, with an operation time of 1-3 hours; 4. Planned to receive general anesthesia; 5. All signed informed consent forms and cooperated in data collection.

Exclusion criteria

Exclusion criteria: 1. The operation duration is less than 1 hour or more than 3 hours; 2. Preoperative uncontrolled hypertension (SBP > 180 mmHg) or sinus bradycardia or arrhythmia; 3. Difficult airway assessment; 4. Poor control of hypertension and suffering from severe heart disease; 5. BMI >= 30 kg/m^2; 6. History of chronic pain; 7. Any other reasons that prevent participation in the study, such as patients with mental disorders, etc. 8. Cancer patients;

Design outcomes

Primary

MeasureTime frame
Self-rating Anxiety Scale score,;Total score of the 40-item Quality of Recovery Scale (QoR-40), and scores of each dimension;Self-rating Depression Scale score;

Countries

China

Contacts

Public ContactZhang Di

Shandong Second Provincial General Hospital, Shandong Provincial ENT Hospital

517366276@qq.com+86 531 8308 6289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026